Pharmaconex 2024
- Pharmaconex 2024 - Egypt (4)
- Pharmaconex 2024 - Egypt (3)
- Pharmaconex 2024 - Egypt (2)
- Pharmaconex 2024 - Egypt (1) - WBCIL
- T J A D S, Jordan, Mr Mousa Daoud - WBCIL
- Sanofi Egypt - WBCIL
- Rowland Pharma, Egypt - WBCIL
- Profect, Egypt - WBCIL
- P&C, Egypt - WBCIL
- Molecules, Jordan - WBCIL
- Misr. S&T, Egypt - WBCIL
- Mepaco, Egypt - WBCIL
- ME Pharma, Egypt - WBCIL
- Jasper, Egypt - WBCIL
- IPC, Egypt - WBCIL
- Import Pharma, Egypt - WBCIL
- Hochster, Egypt - WBCIL
- Eva Pharma - WBCIL
- Esraa Pharma, Egypt - WBCIL
- Dr. Paul Louhman - WBCIL
WBCIL’s Participation in Pharmaconex
West Bengal Chemical Industries Limited (WBCIL) is proud to be a part of Pharmaconex 2024, representing India’s burgeoning pharmaceutical industry. We have been participating Pharmaconex Egypt since 2017 and this will be the 5th times for WBCIL to participate once more. We were an active participant at every pharma conferences 2023.
At our stall H4E22, we will be showcasing:
Our latest iron and calcium APIs including liposomal iron, ferrous ascorbate, ferric carboxymaltose, Ferric ammonium citrate, ferric citrate, Iron isomaltoside, ferrous asparto glycinate, calcium orotate, calcium pidolate, calcium citrate malate, ferric pyrophosphate and more.
- Innovative drug formulations and delivery systems
- Cutting-edge quality control and assurance processes
- Sustainable and eco-friendly packaging solutions
- Pharma trends of 2024
- Our contributions to the global pharmaceutical supply chain
Visit us to explore potential partnerships, learn about our latest innovations, and discuss how WBCIL can support your pharmaceutical needs in Egypt and beyond.
India’s Contribution to Egypt’s Pharmaceutical Industry
India has emerged as a key player in Egypt’s pharmaceutical landscape, contributing significantly to the growth and development of the sector. Some notable contributions include:
- Technology Transfer: Indian companies have been instrumental in transferring advanced pharmaceutical technologies to Egyptian manufacturers.
- Joint Ventures: Numerous collaborations between Indian and Egyptian pharma companies have led to the establishment of world-class manufacturing facilities in Egypt.
- Affordable Medicines: Indian generic drugs have played a crucial role in making essential medicines more accessible and affordable for the Egyptian population.
- Capacity Building: Indian experts have been involved in training Egyptian professionals, enhancing local capabilities in pharmaceutical research and manufacturing.
- Investment: Significant Indian investments in Egypt’s pharma sector have boosted local production capabilities and created employment opportunities.
- Research and Development: Collaborative R&D efforts between Indian and Egyptian institutions have accelerated various formulation discovery and development processes.
As we participate in Pharmaconex 2024, WBCIL reaffirms its commitment to strengthening the Indo-Egyptian partnership in the pharmaceutical sector.
We invite you to join us in exploring the myriad opportunities for collaboration and growth.
Visit us at Hall H4E22 during Pharmaconex 2024 to witness firsthand how India and Egypt are working together to shape the future of pharmaceuticals in the region and beyond.
Don’t miss this opportunity to be part of the pharmaceutical revolution.
See you at Pharmaconex 2024!